Coagulopathy parameters in patients with Crimean-Congo hemorrhagic fever and its relation with mortality

Journal of Clinical Laboratory Analysis

Volumn 24, Issue 3, 2010, Pages 163-166

  Onguru, Pinar ^a   Dagdas, S ^a   Bodur, H ^a   Yilmaz, M ^a   Akinci, E ^a   Eren, S ^a   Ozet, G ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Activated protein C resistance; Antithrombin III; Crimean Congo hemorrhagic fever; Protein C; Protein S

Indexed keywords

ANTITHROMBIN III; D DIMER; FIBRINOGEN; PROTEIN C; PROTEIN S;

ACTIVATED PROTEIN C RESISTANCE; ARTICLE; BLEEDING; BLOOD CLOTTING; CONTROLLED STUDY; CORRELATIONAL STUDY; CRIMEAN CONGO HEMORRHAGIC FEVER; FEVER; FIBRINOGEN BLOOD LEVEL; FOLLOW UP; HUMAN; INTERNATIONAL NORMALIZED RATIO; MAJOR CLINICAL STUDY; MALAISE; MORTALITY; MYALGIA; PREDICTION; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; THROMBOCYTE COUNT; THROMBOPLASTIN TIME;

ACTIVATED PROTEIN C RESISTANCE; ANTITHROMBIN III; BLOOD COAGULATION FACTORS; BLOOD COAGULATION TESTS; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; HEMORRHAGE; HEMORRHAGIC FEVER, CRIMEAN; HUMANS; INTERNATIONAL NORMALIZED RATIO; MALE; PARTIAL THROMBOPLASTIN TIME; PLATELET COUNT; PROGNOSIS; PROTEIN C; PROTEIN S; PROTHROMBIN TIME; RISK FACTORS;

EID: 77953530651     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20383     Document Type: Article

References (17)

1. Whitehouse CA. Crimean-Congo hemorrhagic fever. Antiviral Res 2004;64:145-160.
2. Swanepoel R, Gill DE, Shepherd AJ, Leman PA, Mynhardt JH, Harvey S. The clinical pathology of Crimean-Congo hemorrhagic fever. Rev Infect Dis 1989;11:794-800.
3. Vorou R, Pierroutsakos IN, Maltezou HC. Crimean-Congo hemorrhagic fever. Curr Oppin Infect Dis 2007;20:495-500.
4. Centers for Disease Control and Prevention (CDC). Update: management of patients with suspected viral hemorrhagic fever-United States. MMWR Morb Mortal Wkly Rep 1995;44:475-479.
5. Cevik MA, Erbay A, Bodur H, et al. Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality. Int J Infect Dis 2008;12:374-379.
6. Cevik MA, Erbay A, Bodur H, et al. Viral load as a predictor of outcome in Crimean-Congo hemorrhagic fever. Clin Infect Dis 2007;45:96-100.
7. Onguru P, Akgul EO, Akinci E, et al. High serum levels of neopterin in patients with Crimean-Congo hemorrhagic fever and its relation with mortality. J Infect 2008;56:366-370.
8. Schnittler HJ, Feldmann H. Viral hemorrhagic fever - a vascular disease?. Thromb Haemost 2003;89:967-972. (Pubitemid 36798147)
9. van Gorp EC, Suharti C, ten Cate H, et al. Infectious diseases and coagulation disorders. J Infect Dis 1999;180:176-186.
10. Avila-Aguero ML, Avila-Aguero CR, Um SL, Soriano-Fallas A, Cañas-Coto A, Yan SB. Systemic host inflammatory and coagulation response in the Dengue virus primo-infection. Cytokine 2004;27:173-179.
11. Ergonul O, Tuncbilek S, Baykam N, Celikbas A, Dokuzoguz B. Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean-Congo hemorrhagic fever. J Infect Dis 2006;193:941-944.
12. Griffin JH, Fernández JA, Gale AJ, Mosnier LO. Activated protein C. J Thromb Haemost 2007;5:73-80.
13. van 't Veer C, Mann KG. Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofactor-II. J Biol Chem 1997;272:4367-4377.
14. Yapar M, Aydogan H, Pahsa A, et al. Rapid and quantitative detection of Crimean-Congo hemorrhagic fever virus by one-step real-time reverse- transcriptase PCR. Jpn J Infect Dis 2005;58:358-362.
15. Nguyen TH, Lei HY, Nguyen TL, et al. Dengue hemorrhagic fever in infants: a study of clinical and cytokine profiles. J Infect Dis 2004;189:221-232.
16. Hensley LE, Stevens EL, Yan SB, et al. Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever. J Infect Dis 2007;196:390-399.
17. Taylor FB, Toh CH, Hoots WK, Wada H, Levi M. Towards definition, clinical and laboratory criteria, and scoring system for disseminated intravascular coagulation. Thromb Haemost 2001;86:1327-1330.